This overview describes the full spectrum of current pre-clinical and clinical kidney-, liver-, heart- and lung transplantation research performed in Erasmus MC - University Medical Centre in Rotterdam, The Netherlands. An update is provided on the development of a large living donor kidney transplantation program and on optimization of kidney allocation, including the implementation of a domino kidney-donation program. Our current research efforts to optimize immunosuppressive regimens and find novel targets for immunosuppressive therapy, our recent studies on prevention of ischemia-reperfusion-induced graft injury, our newest findings on stimulation of tissue regeneration, our novel approaches to prevent rejection and viral infection, and our latest insights in the regulation of allograft rejection, are summarized.

Additional Metadata
Keywords Dietary restriction, Immunosuppressive drug, Living donation, Mesenchymal stromal cell, MicroRNA, Regulatory T cell
Persistent URL dx.doi.org/10.1016/j.trim.2014.09.005, hdl.handle.net/1765/81046
Journal Transplant Immunology
Citation
Kwekkeboom, J, van der Laan, L.J.W, Betjes, M.G.H, Manintveld, O.C, Hoek, R.A.S, Cransberg, K, … Baan, C.C. (2014). Rotterdam: Main port for organ transplantation research in the Netherlands. Transplant Immunology, 31(4), 200–206. doi:10.1016/j.trim.2014.09.005